Welcome to the CADTH Communiqué — your main information source for news and updates on the Canadian Agency for Drugs and Technologies in Health’s (CADTH’s) research, products, and services.

The CADTH Communiqué contains the latest information on CADTH optimal use recommendations and tools, health technology assessments, Common Drug Review recommendations and initiatives, opportunities to provide feedback, and new and emerging health technologies that could significantly impact the health care of Canadians.

If you previously subscribed to the COMPUS Communiqué, CDR Update, or other CADTH e-publications, your subscription was automatically transferred to the CADTH Communiqué.

You may subscribe or unsubscribe to the CADTH Communiqué at any time.